Search
for

    Sort by

    Research 901–930 of 1000+

    1. The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride International Braz J Urol · 2008 · 24 citations
    2. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    3. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5α-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat 3 3Abbreviations: r5AR1, rat 5α-reductase 1; r5AR2, rat 5α-reductase 2; and DHT, dihydrotestosterone. Biochemical Pharmacology · 2001 · 22 citations
    4. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? Current Drug Targets · 2015 · 21 citations
    5. Intracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release Mechanism 2016 · 19 citations
    6. Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors Steroids · 2010 · 19 citations
    7. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    8. Uromedic® Pumpkin Seed Derived Δ7-Sterols, Extract and Oil Inhibit 5α-Reductases and Bind to Androgen Receptor <em>in Vitro</em> Pharmacology & pharmacy · 2018 · 12 citations
    9. The prevention of benign prostatic hyperplasia (bph) Medical Hypotheses · 2016 · 12 citations
    10. Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line European Journal of Medicinal Chemistry · 2016 · 11 citations
    11. Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2 Steroids · 2017 · 8 citations
    12. A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats Saudi Journal of Biological Sciences · 2015 · 8 citations
    13. 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro The Journal of Steroid Biochemistry and Molecular Biology · 2019 · 7 citations
    14. Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll? Der Urologe · 2002 · 4 citations
    15. Theoretical Evaluation of Twenty-Cannabinoid Derivatives on Either Androgen Receptor or 5α-Reductase Enzyme Clinical cancer investigation journal · 2023 · 3 citations
    16. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system Research and reports in urology · 2016 · 3 citations
    17. Evaluation of men on finasteride. PubMed · 1996 · 3 citations
    18. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    19. Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq Baghdad Science Journal · 2020 · 2 citations
    20. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system DOAJ (DOAJ: Directory of Open Access Journals) · 2016 · 2 citations
    21. Experimental and theoretical studies on the interaction of finasteride with chitosan-based nanoniosomes Journal of molecular structure · 2024 · 1 citations
    22. The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH World Journal of Urology · 2023 · 1 citations
    23. Effect of metabolic syndrome on treatment outcome of lower urinary tract symptoms in males due to benign prostatic hyperplasia Panacea Journal of Medical Sciences · 2020 · 1 citations
    24. Finasterid in der Behandlung der benignen Prostatahyperplasie Der Urologe · 2012 · 1 citations
    25. Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity Arzneimittelforschung · 2011 · 1 citations
    26. Retorno de la fertilidad en un perro con un abscesso prostático Clinica Veterinaria De Pequenos Animales · 2010 · 1 citations
    27. EFFECTS OF FESOTERODINE, A NOVEL ANTIMUSCARINIC, ALONE AND IN COMBINATION WITH AN α-RECEPTOR BLOCKER, DOXAZOSIN, ON BLADDER FUNCTION IN OBSTRUCTED RATS The Journal of Urology · 2009 · 1 citations
    28. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    29. Гормональный дисбаланс как фактор развития хронического простатита: механизмы и перспективы терапии Репродуктивное здоровье Восточная Европа · 2025
    30. The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review Consilium Medicum · 2025